Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 09/30/2019

Month EndAs of 10/31/2019 1 Yr 3 Yr 5 Yr 10 Yr Since Inception Inception 09/15/1997
Fund without Sales Charge (%) (NAV) 7.75 7.63 1.26 15.28 10.55
Fund with Sales Charge (%) (POP) 1.82 5.61 0.12 14.63 10.27
NASDAQ Biotechnology Index (%) 2.87 7.90 1.66 16.24 11.20
S&P 500 Index (%) 14.33 14.92 10.78 13.70 7.56
Quarter EndAs of 09/30/2019 1 Yr 3 Yr 5 Yr 10 Yr Since Inception Inception 09/15/1997
Fund without Sales Charge (%) (NAV) -17.49 0.01 0.70 13.02 10.06
Fund with Sales Charge (%) (POP) -22.02 -1.85 -0.44 12.38 9.78
NASDAQ Biotechnology Index (%) -18.45 1.10 1.81 14.19 10.87
S&P 500 Index (%) 4.25 13.40 10.84 13.24 7.48

Calendar Year Returns

2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund without Sales Charge (%) (NAV) -15.72 18.80 -17.16 5.50 33.91 68.64 29.35 8.35 17.28 11.83
Fund with Sales Charge (%) (POP) -20.35 11.97 -21.92 -0.57 26.22 58.95 21.90 2.12 10.54 5.41
NASDAQ Biotechnology Index (%) -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25 15.84
S&P 500 Index (%) -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06 26.46

Cumulative Total Returns [further-information] As of 09/30/2019

Month EndAs of 10/31/2019 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 18.20 7.75 24.67 6.44 314.51 820.27
Fund with Sales Charge (%) (POP) 11.70 1.82 17.81 0.59 291.74 769.50
NASDAQ Biotechnology Index (%) 10.71 2.87 25.61 8.60 350.45 947.53
S&P 500 Index (%) 23.16 14.33 51.73 66.81 260.96 401.02
Quarter EndAs of 09/30/2019 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 6.21 -17.49 0.04 3.54 239.92 726.94
Fund with Sales Charge (%) (POP) 0.37 -22.02 -5.46 -2.16 221.19 681.31
NASDAQ Biotechnology Index (%) 2.76 -18.45 3.32 9.39 276.85 872.33
S&P 500 Index (%) 20.55 4.25 45.80 67.27 246.74 390.39

After-Tax Average Annual Total Returns [further-information] As of 09/30/2019

Month EndAs of 10/31/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 6.55 6.57 -0.09 14.05
Fund without Sales Charge (%) (NAV) After Shares Sold 4.78 5.64 0.64 12.60
Fund with Sales Charge (%) (POP) Before Shares Sold 0.68 4.58 -1.21 13.41
Fund with Sales Charge (%) (POP) After Shares Sold 1.25 4.06 -0.23 12.01
Quarter EndAs of 09/30/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -18.41 -0.97 -0.64 11.81
Fund without Sales Charge (%) (NAV) After Shares Sold -10.13 -0.17 0.29 10.64
Fund with Sales Charge (%) (POP) Before Shares Sold -22.90 -2.81 -1.75 11.18
Fund with Sales Charge (%) (POP) After Shares Sold -12.83 -1.57 -0.57 10.07

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 1.04%
Net Expense Ratio [further-information] 1.02%
Max Initial Sales Charge 5.50%
CDSC 1.00%

Volatility Measures [further-information] As of 10/31/2019 Updated Monthly, based on a 3-year period

Beta 1.08
Sharpe Ratio 0.27
Standard Deviation 22.39

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index